The Cost‐Effectiveness of a Multi‐Target Stool DNA ‐Based Screening ( COLOTECT ), FIT , Colonoscopy and No Screening for Colorectal Cancer
Cancer Reports · 2025
DOI: 10.1002/cnr2.70176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Junjie Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonoscopy, Early Detection of Cancer, Feces. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Around 1.9 million new cases and 1 million deaths worldwide were attributed to colorectal cancer (CRC) in 2020.
Aims
The aims of this study are to assess the cost‐effectiveness of a multi‐target stool DNA‐based screening strategy, COLOTECT, compared to faecal immunochemical tests (FIT), colonoscopy, and no screening in the Asian population to inform more choices for policymakers in colorectal cancer screening. Method and Results We assume that 100,000 persons aged 50 undergo annual FIT, annual COLOTECT multi‐target testing, or colonoscopies every 10 years until age 75. The data used in this study was retrieved from different sources including the Hong Kong Cancer Registry and previously published studies on the population aged 50 to 75 years old between 2010 and 2023. This study accessed the most cost‐effective screening strategy available. If a positive result of FIT or COLOTECT were observed, the participants would undergo a colonoscopy. The participants who used the colonoscopy as the main screening method conducted colonoscopies every 3 years. The Markov models were utilized to compare the outcomes from different strategies including life‐years saved, years of life lost, and incremental cost‐effectiveness ratio (primary outcome). The highest ICER was observed in colonoscopy (USD 160808), followed by FIT (USD 108952), and COLOTECT (USD 82206). A higher detection rate of CRC (COLOTECT: 39.3% vs. FIT: 4.5%), more CRC cases prevented (1272 vs. 146), and life‐years saved (2295 vs. 337) were observed in the COLOTECT strategy than in FIT. Additionally, a lower total cost per life‐year saved of COLOTECT (USD 180097) was observed than colonoscopy (USD 238356), which identified the more affordable and cost‐saving COLOTECT strategy.
Conclusion
This study highlighted the better performance of COLOTECT than FIT in detecting CRC. Additionally, given its lower cost and higher acceptance, the COLOTECT strategy might be more cost‐effective than colonoscopy for massive CRC screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR.
- Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR.
- Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
- Department of Electrical Engineering and Automation, Guangdong Ocean University, Zhanjiang, Guangdong, China.
- Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
- Cancer Hospital & Shenzhen Hospital, Beijing, Chinese Academy of Medical Sciences and Peking Union Medical College, China.
ORCID-Profile: Junjie Huang, Mingtao Chen, Junjie Hang
Zitieren
APA
Huang, J., Chen, M., Chan, V. C. W., Liu, X., Zhong, C., Lin, J., Hang, J., Zhong, C. C., Yuan, J., & Wong, M. C. S. (2025). The Cost‐Effectiveness of a Multi‐Target Stool DNA ‐Based Screening ( COLOTECT ), FIT , Colonoscopy and No Screening for Colorectal Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70176
Vancouver
Huang J, Chen M, Chan VCW, Liu X, Zhong C, Lin J, et al. The Cost‐Effectiveness of a Multi‐Target Stool DNA ‐Based Screening ( COLOTECT ), FIT , Colonoscopy and No Screening for Colorectal Cancer. Cancer Reports. 2025. doi:10.1002/cnr2.70176
BibTeX
@article{Huang2025,
author = {Huang, Junjie and Chen, Mingtao and Chan, Victor C W and Liu, Xianjing and Zhong, Chaoying and Lin, Jianli and Hang, Junjie and Zhong, Claire Chenwen and Yuan, Jinqiu and Wong, Martin C S},
title = {The Cost‐Effectiveness of a Multi‐Target Stool DNA ‐Based Screening ( COLOTECT ), FIT , Colonoscopy and No Screening for Colorectal Cancer},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70176}
}
EUVIMED